Sunshine Biopharma- Warrants (15/02/2027) Profit Margin

Sunshine Biopharma- Warrants (15/02/2027)'s profit margin stands at -16.5% as of June 2026. That compares with -17.35% in the prior-year period — up 4.9% year over year. That is below the Healthcare sector average of 21.34%. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

Sunshine Biopharma- Warrants (15/02/2027) reported -16.5% in profit margin versus -17.35% a year earlier — a 4.9% year-over-year increase. The historical chart on this page makes it easier to see whether that move is part of a longer pattern.

Sunshine Biopharma- Warrants (15/02/2027) sits lower the Healthcare benchmark (21.34%) with a profit margin of -16.5%. That is roughly 177.3% below the sector mean. Peer context matters because what looks expensive or cheap in absolute terms can be normal for the sector.

A profit margin of -16.5% for Sunshine Biopharma- Warrants (15/02/2027) means each unit of related capital or sales is generating that return rate. Higher is usually better for profitability metrics, but extremely high figures can reflect one-time items or thin equity bases. Review several years of data on this page before extrapolating.

The history chart shows how Sunshine Biopharma- Warrants (15/02/2027)'s profit margin evolved across reporting periods, while the comparison chart places SBFMW next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.